期刊文献+

(3S,6S)-及(3S,6R)-3-苄氧甲基-6-甲基-吗啉-2,5-二酮的制备及其晶体结构 被引量:1

Synthesis and Crystal Structures of Chiral(3S,6S)-and(3S,6R)-3-Benzyloxymethyl-6-methyl-morpholine-2,5-dione
下载PDF
导出
摘要 以2-溴丙酸和N-叔丁氧羰基-O-苄基-L-丝氨酸为起始试剂首先制得N-(2-溴丙基)-O-苄基-L-丝氨酸(BPBS),在N,N-二甲基甲酰胺(DMF)/三乙胺(Et3N)溶剂中80℃经9h后BPBS发生分子内环化反应生成(3S,6S)-3-苄氧甲基-6-甲基-吗啉-2,5-二酮[(3S,6S)-BMMD]及(3S,6R)-BMMD共存体,产率70%.将所制得的共存体以乙酸乙酯为重结晶溶剂,采用微分重结晶法,经4次"溶解-部分重结晶"操作循环制得两种纯光学构型的(3S,6S)-BMMD和(3S,6R)-BMMD.将两种光学纯双手性中心的BMMD分别溶于乙酸乙酯,室温下培养得(3S,6S)-BMMD和(3S,6R)-BMMD的单晶体,以X射线衍射法测定上述两种BMMD的分子结构. N-(2-Bromopropionyl)-O-benzyl-L-serine (BPBS) was prepared using 2-bromopropionic acid and N-Boc-O-Bzl-L-serine as the starting reagents. BPBS underwent the intra-molecular ring-closing reac- tion in DMF/Et3N solvent at 80 ℃ for 9 h forming a mixture of two non-enantiomers, i.e. (3S,6S)-benzyloxymethyl-6-methyl-morpholine-2,5-dione [(3S,6S)-BMMD] and (3S,6R)-BMMD with a yield of 70%. Two optically pure enantiomers of BMMD, i.e. (3S,6S)-BMMD and (3S,6R)-BMMD were obtained via 4 operation circles of "solution-partial recrystallization" by means of a differential recrystallization method using ethyl acetate as a solvent. The single crystals of the two isomers of BMMD were grown from ethyl acetate at room temperature. The fine molecular structures of the two isomers were determined by X-ray diffraction analysis of the single crystals.
出处 《有机化学》 SCIE CAS CSCD 北大核心 2009年第5期737-742,共6页 Chinese Journal of Organic Chemistry
基金 国家自然科学基金(No.20474030)资助项目
关键词 (3S 6S)-3-苄氧甲基-6-甲基-吗啉-2 5-二酮 (3S 6R)-3-苄氧甲基-6-甲基-吗啉-2 5-二酮 拆分 光学异构体 晶体结构 (3S,6S)-benzyloxymethyl-6-methyl-morpholine-2,5-dione (3S,6R)-benzyloxymethyl-6-methyl- morpholine-2,5-dione resolution optical isomer crystal structure
  • 相关文献

参考文献16

  • 1Mainivaxlet,P.;Rahm,R.;Gogolewski,S.Biomaterials 1997,18,257. 被引量:1
  • 2Middleton,J.C.;Tipton,A.J.Biomaterials 2000,21,2335. 被引量:1
  • 3Perogo,G.;Cella,G.D.;Aldin,N.N.;Fini,M.;Giardino,R.Biomaterials 1994,15,189. 被引量:1
  • 4Kylma,J.;Seppala,J.V.Macromolecules 1997,30,2876. 被引量:1
  • 5Langer,R.Nature 1998,392,5. 被引量:1
  • 6Kataoka,K.;Harada,A.;Nagasaki,Y.Adv.Drug Delivery Rev.2001,47,113. 被引量:1
  • 7Barrera,D.A.;Zylstra,E.;Lansbury,P.T.;Langer,R.Macromolecules 1995,28,425. 被引量:1
  • 8Barrera,D.A.;Zylstra,E.;Lansbury,P.T.;Langer,R.J.Am.Chem.Soc.1993,115,11010. 被引量:1
  • 9Li,F.;Zhang,H.;Jiang,L.Magn.Reson.Chem.2007,45,929. 被引量:1
  • 10Feng,Y.;klee,D.;keul,H.;Hocker,H.Macromol.Chem.Phys.2000,201,2670. 被引量:1

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部